313.39
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $313.39, with a volume of 2.91M.
It is down -0.46% in the last 24 hours and up +4.65% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$314.84
Open:
$317.16
24h Volume:
2.91M
Relative Volume:
1.13
Market Cap:
$120.14B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
36.30
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
-0.09%
1M Performance:
+4.65%
6M Performance:
-10.83%
1Y Performance:
-21.01%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
313.39 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
ABT
Abbott Laboratories
|
92.18 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
MDT
Medtronic Plc
|
79.20 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
43.06 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
91.99 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Workers Withdraw Claims in Stryker Wiper Attack Lawsuit - BankInfoSecurity
Stryker cyberattack lawsuits dismissed - WZZM13.com
Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation - Yahoo Finance
Stryker Corp. focuses on medical technology growth as investors track its U.S. hospital exposure - AD HOC NEWS
Stryker schedules July 30 webcast on Q2 2026 results - Stock Titan
The Stryker System 6 power toola workhorse surgical drill built for OR reliability - AD HOC NEWS
Stryker Corp (SYK) Stock Down 4.7% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Stryker Corp Stock (SYK) Moved Down by 5.31% on Jun 30: Key Drivers Unveiled - TradingKey
Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base - Yahoo Finance
Stryker, analyst consensus stays constructive, shares trade near recent highs - AD HOC NEWS
Is Stryker Corporation (SYK) A Good Stock To Buy Now? - Yahoo Finance
Stryker reports index change, shares hold their ground on NYSE - AD HOC NEWS
Stryker family - Forbes
Stryker Corporation (SYK) launches TPX HD® Power Tool - Insider Monkey
Stryker Corp clears weekly gain, shares extend June rebound - Ad-hoc-news.de
The Sonopet iQ Ultrasonic Aspirator from Stryker Corp.quieter bone cutting in complex neurosurger - Ad-hoc-news.de
Stryker Corp (SYK) Shares Surge 5.2% -- What GF Score of 92 Tells Investors - GuruFocus
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker recasts prior periods after reorganizing to create Ortho Tech, maintains two reportable segments - TradingView
Stryker (SYK) reshapes segments, buys Inari and lifts 2025 EPS - Stock Titan
Stryker Jumps as Investors Reassess Recovery Story and MedTech Outlook - Moomoo
Stryker updates 2026 outlook, shares hold near $316 - Ad-hoc-news.de
Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss - Insider Monkey
Stryker Corp (SYK) Institutional Confidence - TradingKey
What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks - Insider Monkey
Stryker Seeks to Dismiss Class Action Lawsuit in Cyberattack - BankInfoSecurity
AB Concentrated Growth Fund's Stryker Corp(SYK) Holding History - GuruFocus
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement - Barchart.com
Stryker cautious after BofA and Barclays trim targets, shares stay firm in S&P 500 - Ad-hoc-news.de
Stryker Says Data Breach Suit Built On Speculation - Law360
The Mako Robotic-Arm Assisted Surgery System from Stryker Corpprecise cuts, consistent knee and h - Ad-hoc-news.de
Stryker shows mixed analyst sentiment, shares hold firm in the S&P 500 - Ad-hoc-news.de
Stryker Corp. stock underperforms Monday when compared to competitors - MarketWatch
Stryker slides, BofA trims target on medtech slowdown - Ad-hoc-news.de
BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show? - Insider Monkey
Why Is S&P 500 Healthcare Watching Stryker’s Robotics Push? - Kalkine Media
Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run - Yahoo Finance
Stryker Corp. StockLong-term drivers in focus for this medical devices leader - Ad-hoc-news.de
Stryker StockSaturday background on the medtech group - Ad-hoc-news.de
Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
SYK News | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker Corp (SYK) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stryker Corp Stock (SYK) Moved Up by 3.03% on Jun 18: What Signal Does It Send? - TradingKey
Jefferies Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $455 - 富途牛牛
Smaller incisions, bigger controlhow Stryker’s OptaBlate BVN spine tool pushes vertebral ablati - Ad-hoc-news.de
Why Stryker’s Mako SmartRobotics system is reshaping knee surgery - Ad-hoc-news.de
Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight - Law360
Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stryker Corp (SYK) Shares Fall 3.0% -- What GF Score of 92 Tells Investors - GuruFocus
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):